Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Alosaimy

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Infectious Diseases and Therapy|May 10, 2022
Clinical Characteristics Associated with Bacterial Bloodstream Coinfection in COVID-19Nicholas Rebold, Sara Alosaimy, Taylor Morrisette, et al.
Open Forum Infectious Diseases|March 13, 2020
Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial InfectionsSara Alosaimy, Sarah C J Jorgensen, Abdalhamid M Lagnf, et al.
Open Forum Infectious Diseases|February 25, 2021
Preliminary, Real-world, Multicenter Experience With Omadacycline for <i>Mycobacterium abscessus</i> InfectionsTaylor Morrisette, Sara Alosaimy, Julie V Philley, et al.
Open Forum Infectious Diseases|December 13, 2021
Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative InfectionsNicholas Rebold, Taylor Morrisette, Abdalhamid M Lagnf, et al.
Open Forum Infectious Diseases|July 14, 2021
Standardized Treatment and Assessment Pathway Improves Mortality in Adults With Methicillin-resistant <i>Staphylococcus aureus</i> Bacteremia: STAPH StudySara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette, et al.
Infectious Diseases and Therapy|March 1, 2024
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational StudyNicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, et al.
Microbiology Spectrum|October 3, 2022
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumanniiSara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf, et al.
Infectious Diseases and Therapy|September 29, 2025
Correction: Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia InfectionsMohammed Al Musawa, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Infectious Diseases and Therapy|June 6, 2025
Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia InfectionsMohammed Al Musawa, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Open Forum Infectious Diseases|August 25, 2021
Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant <i>Enterobacterales</i> and <i>Pseudomonas aeruginosa</i>Sara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Infectious Diseases and Therapy|May 10, 2022
Clinical Characteristics Associated with Bacterial Bloodstream Coinfection in COVID-19Nicholas Rebold, Sara Alosaimy, Taylor Morrisette, et al.
Open Forum Infectious Diseases|March 13, 2020
Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial InfectionsSara Alosaimy, Sarah C J Jorgensen, Abdalhamid M Lagnf, et al.
Open Forum Infectious Diseases|February 25, 2021
Preliminary, Real-world, Multicenter Experience With Omadacycline for <i>Mycobacterium abscessus</i> InfectionsTaylor Morrisette, Sara Alosaimy, Julie V Philley, et al.
Open Forum Infectious Diseases|December 13, 2021
Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative InfectionsNicholas Rebold, Taylor Morrisette, Abdalhamid M Lagnf, et al.
Open Forum Infectious Diseases|July 14, 2021
Standardized Treatment and Assessment Pathway Improves Mortality in Adults With Methicillin-resistant <i>Staphylococcus aureus</i> Bacteremia: STAPH StudySara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette, et al.
Infectious Diseases and Therapy|March 1, 2024
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational StudyNicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, et al.
Microbiology Spectrum|October 3, 2022
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumanniiSara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf, et al.
Infectious Diseases and Therapy|September 29, 2025
Correction: Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia InfectionsMohammed Al Musawa, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Infectious Diseases and Therapy|June 6, 2025
Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia InfectionsMohammed Al Musawa, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Open Forum Infectious Diseases|August 25, 2021
Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant <i>Enterobacterales</i> and <i>Pseudomonas aeruginosa</i>Sara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette, et al.
Pageof 4